| Feb 3, 2026 |
Feb 5, 2026 |
Wettig Thane
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 3, 2026 |
Feb 5, 2026 |
DeLucia David
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Dec 6, 2025 |
Dec 9, 2025 |
DeLucia David
|
CFO |
Sell |
27.5
|
-52
|
-1.15%
|
✗
|
$437.8 |
| Dec 6, 2025 |
Dec 9, 2025 |
Wettig Thane
|
CEO |
Sell |
27.5
|
-259
|
-1.04%
|
✗
|
$2.2K |
| Nov 13, 2025 |
Nov 17, 2025 |
Wettig Thane
|
CEO |
Buy |
91.3
|
+3,700
|
17.39%
|
✗
|
$33.7K |
| Jun 6, 2025 |
Sep 9, 2025 |
DeLucia David
|
CFO |
Sell |
27.5
|
-104
|
-2.24%
|
✗
|
$1K |
| Jun 6, 2025 |
Sep 9, 2025 |
Wettig Thane
|
CEO |
Sell |
27.5
|
-494
|
-2.27%
|
✗
|
$4.9K |
| Jun 30, 2025 |
Jul 2, 2025 |
Schoeneck James A
|
Director |
Buy |
95.0
|
+23,567
|
146.39%
|
✗
|
$119.5K |
| Jun 4, 2025 |
Jun 6, 2025 |
Ho Maykin
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 4, 2025 |
Jun 6, 2025 |
EDWARDS JEFFREY L
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 4, 2025 |
Jun 6, 2025 |
Schoeneck James A
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 4, 2025 |
Jun 6, 2025 |
Kauffman Michael
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Jun 6, 2025 |
Kauffman Michael
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 24, 2025 |
Mar 25, 2025 |
Wettig Thane
|
CEO |
Buy |
95.0
|
+145,000
|
36.31%
|
✗
|
$50.7K |
| Mar 20, 2025 |
Mar 24, 2025 |
Schoeneck James A
|
Director |
Buy |
95.0
|
+300,000
|
292.72%
|
✗
|
$105K |
| Mar 6, 2025 |
Mar 7, 2025 |
Wettig Thane
|
CEO |
Sell |
27.5
|
-21,624
|
-5.14%
|
✗
|
$8.7K |
| Mar 6, 2025 |
Mar 7, 2025 |
Chung Christine
|
SVP, CHINA OPERATIONS |
Sell |
27.5
|
-6,649
|
-2.20%
|
✗
|
$2.9K |
| Mar 6, 2025 |
Mar 7, 2025 |
DeLucia David
|
CFO |
Sell |
27.5
|
-2,325
|
-1.96%
|
✗
|
$906.8 |
| Jan 9, 2025 |
Jan 10, 2025 |
DeLucia David
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 9, 2025 |
Jan 10, 2025 |
Wettig Thane
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Dec 18, 2024 |
DeLucia David
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Dec 6, 2024 |
Dec 9, 2024 |
Graham Juan
|
CFO |
Sell |
27.5
|
-2,512
|
-1.50%
|
✗
|
$859.4 |
| Dec 6, 2024 |
Dec 9, 2024 |
Wettig Thane
|
CEO |
Sell |
37.5
|
-2,363
|
-0.56%
|
✗
|
$808.4 |
| Dec 6, 2024 |
Dec 9, 2024 |
Chung Christine
|
SVP, CHINA OPERATIONS |
Sell |
37.5
|
-2,792
|
-0.92%
|
✗
|
$955.1 |
| Sep 6, 2024 |
Sep 9, 2024 |
Graham Juan
|
CFO |
Sell |
27.5
|
-17,115
|
-9.28%
|
✗
|
$6.7K |
| Sep 6, 2024 |
Sep 9, 2024 |
Wettig Thane
|
CEO |
Sell |
37.5
|
-2,363
|
-0.56%
|
✗
|
$921.6 |
| Sep 6, 2024 |
Sep 9, 2024 |
Chung Christine
|
SVP, CHINA OPERATIONS |
Sell |
27.5
|
-17,395
|
-5.41%
|
✗
|
$6.8K |
| Aug 1, 2024 |
Aug 5, 2024 |
Wettig Thane
|
CEO |
Sell |
27.5
|
-20,840
|
-4.67%
|
✗
|
$9.8K |
| Jun 22, 2024 |
Jun 25, 2024 |
Wettig Thane
|
CEO |
Sell |
52.5
|
-782
|
-0.17%
|
✗
|
$883.7 |
| Jun 12, 2024 |
Jun 13, 2024 |
Adib Deyaa
|
Chief Medical Officer |
Buy |
91.3
|
+22,123
|
36.87%
|
✗
|
$25.9K |
| Jun 6, 2024 |
Jun 10, 2024 |
Graham Juan
|
CFO |
Sell |
26.3
|
-18,979
|
-9.33%
|
✗
|
$22.5K |
| Jun 6, 2024 |
Jun 7, 2024 |
Chung Christine
|
SVP, CHINA OPERATIONS |
Sell |
26.3
|
-19,289
|
-5.66%
|
✗
|
$23K |
| Jun 6, 2024 |
Jun 7, 2024 |
Wettig Thane
|
CEO |
Sell |
37.5
|
-2,255
|
-0.50%
|
✗
|
$2.7K |
| Jun 5, 2024 |
Jun 6, 2024 |
Schoeneck James A
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 5, 2024 |
Jun 6, 2024 |
Lema Gerald
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 5, 2024 |
Jun 6, 2024 |
Ho Maykin
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 5, 2024 |
Jun 6, 2024 |
Cravatt Benjamin
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 5, 2024 |
Jun 6, 2024 |
EDWARDS JEFFREY L
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 5, 2024 |
Jun 6, 2024 |
Brennan Aoife
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 5, 2024 |
Jun 6, 2024 |
Blaug Suzanne
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 1, 2024 |
May 2, 2024 |
Wettig Thane
|
CEO |
Sell |
26.3
|
-20,840
|
-4.43%
|
✗
|
$24.4K |
|
Apr 24, 2024 |
Adib Deyaa
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 22, 2024 |
Mar 25, 2024 |
Wettig Thane
|
CEO |
Sell |
52.5
|
-782
|
-0.17%
|
✗
|
$2K |
| Mar 7, 2024 |
Mar 11, 2024 |
Wettig Thane
|
CEO |
Buy |
95.0
|
+50,000
|
11.87%
|
✗
|
$95.5K |
| Mar 6, 2024 |
Mar 8, 2024 |
Graham Juan
|
CFO |
Sell |
26.3
|
-21,149
|
-9.42%
|
✗
|
$40.9K |
| Mar 6, 2024 |
Mar 8, 2024 |
Wettig Thane
|
CEO |
Sell |
37.5
|
-3,754
|
-0.88%
|
✗
|
$8.5K |
| Mar 6, 2024 |
Mar 8, 2024 |
Chung Christine
|
SVP, CHINA OPERATIONS |
Sell |
26.3
|
-22,809
|
-6.27%
|
✗
|
$44.1K |
| Feb 21, 2024 |
Feb 23, 2024 |
Wettig Thane
|
CEO |
Neutral |
90.0
|
+166,000
|
64.11%
|
✗
|
- |
| Feb 21, 2024 |
Feb 23, 2024 |
Chung Christine
|
SVP, CHINA OPERATIONS |
Neutral |
85.0
|
+29,000
|
8.66%
|
✗
|
- |
| Feb 21, 2024 |
Feb 23, 2024 |
Graham Juan
|
CFO |
Neutral |
90.0
|
+52,000
|
30.12%
|
✗
|
- |
| Feb 1, 2024 |
Feb 5, 2024 |
Wettig Thane
|
CEO |
Sell |
22.5
|
-23,490
|
-8.32%
|
✗
|
$55.7K |
| Dec 22, 2023 |
Dec 26, 2023 |
Wettig Thane
|
CEO |
Sell |
45.0
|
-819
|
-0.29%
|
✗
|
$622.4 |
| Dec 6, 2023 |
Dec 11, 2023 |
Graham Juan
|
CFO |
Sell |
27.5
|
-16,658
|
-8.80%
|
✗
|
$9.7K |
| Dec 6, 2023 |
Dec 11, 2023 |
Chung Christine
|
SVP, China Operations |
Sell |
26.3
|
-18,182
|
-5.15%
|
✗
|
$10.5K |
| Dec 6, 2023 |
Dec 11, 2023 |
Wettig Thane
|
CEO |
Sell |
37.5
|
-1,680
|
-0.59%
|
✗
|
$974.4 |
| Nov 1, 2023 |
Nov 3, 2023 |
Wettig Thane
|
CEO |
Sell |
26.3
|
-21,841
|
-7.12%
|
✗
|
$11.9K |
| Sep 22, 2023 |
Sep 25, 2023 |
Wettig Thane
|
CEO |
Sell |
45.0
|
-819
|
-0.27%
|
✗
|
$644 |
| Sep 6, 2023 |
Sep 8, 2023 |
Graham Juan
|
CFO |
Sell |
37.5
|
-1,807
|
-0.95%
|
✗
|
$1.8K |
| Sep 6, 2023 |
Sep 8, 2023 |
Wettig Thane
|
CEO |
Sell |
37.5
|
-1,680
|
-0.54%
|
✗
|
$1.6K |
| Sep 6, 2023 |
Sep 8, 2023 |
Eisner Mark
|
EVP, Chief Medical Officer |
Sell |
27.5
|
-1,860
|
-1.15%
|
✗
|
$1.8K |
| Sep 6, 2023 |
Sep 8, 2023 |
Chung Christine
|
SVP, China Operations |
Sell |
37.5
|
-3,308
|
-0.93%
|
✗
|
$3.2K |
| Sep 1, 2023 |
Sep 6, 2023 |
Eisner Mark
|
EVP, Chief Medical Officer |
Sell |
37.5
|
-1,085
|
-0.67%
|
✗
|
$1.2K |
| Sep 1, 2023 |
Sep 6, 2023 |
Henderson Jeffrey William
|
Director |
Sell |
37.5
|
-2,000
|
-6.48%
|
✓
|
$2.1K |
| Aug 30, 2023 |
Sep 1, 2023 |
Graham Juan
|
CFO |
Neutral |
90.0
|
+120,000
|
168.82%
|
✗
|
- |
| Aug 30, 2023 |
Sep 1, 2023 |
Chung Christine
|
SVP, China Operations |
Neutral |
90.0
|
+120,000
|
50.78%
|
✗
|
- |
| Aug 10, 2023 |
Aug 14, 2023 |
Schoeneck James A
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Aug 7, 2023 |
Aug 9, 2023 |
Wettig Thane
|
Chief Commercial Officer |
Neutral |
90.0
|
+200,000
|
184.74%
|
✗
|
- |
| Aug 4, 2023 |
Aug 8, 2023 |
Henderson Jeffrey William
|
Director |
Sell |
37.5
|
-2,000
|
-6.09%
|
✓
|
$3.8K |
| Jul 11, 2023 |
Jul 13, 2023 |
Henderson Jeffrey William
|
Director |
Sell |
37.5
|
-2,000
|
-5.74%
|
✓
|
$5.4K |
| Jul 7, 2023 |
Jul 10, 2023 |
Conterno Enrique A
|
CEO |
Sell |
45.0
|
-1,880
|
-0.46%
|
✗
|
$5.3K |
| Jun 23, 2023 |
Jun 26, 2023 |
Wettig Thane
|
Chief Commercial Officer |
Sell |
36.3
|
-791
|
-0.73%
|
✗
|
$13.1K |
| Jun 7, 2023 |
Jun 22, 2023 |
Wettig Thane
|
Chief Commercial Officer |
Sell |
26.3
|
-1,758
|
-1.59%
|
✗
|
$30K |
| Jun 13, 2023 |
Jun 15, 2023 |
Chung Christine
|
SVP, China Operations |
Sell |
32.5
|
-12,500
|
-5.02%
|
✓
|
$214.9K |
| Jun 7, 2023 |
Jun 9, 2023 |
Cravatt Benjamin
|
Director |
Sell |
95.0
|
+4,345
|
17.81%
|
✓
|
$67.7K |
| Jun 7, 2023 |
Jun 9, 2023 |
Brennan Aoife
|
Director |
Sell |
95.0
|
+3,556
|
14.58%
|
✓
|
$81.4K |
| Jun 7, 2023 |
Jun 9, 2023 |
Blaug Suzanne
|
Director |
Sell |
47.5
|
-231
|
-0.77%
|
✓
|
$146.6K |
| Jun 7, 2023 |
Jun 9, 2023 |
Ho Maykin
|
Director |
Sell |
47.5
|
-231
|
-0.73%
|
✓
|
$148.6K |
| Jun 7, 2023 |
Jun 9, 2023 |
Lema Gerald
|
Director |
Neutral |
90.0
|
+8,289
|
22.36%
|
✗
|
- |
| Jun 7, 2023 |
Jun 9, 2023 |
EDWARDS JEFFREY L
|
Director |
Sell |
82.5
|
+400
|
1.19%
|
✓
|
$135.6K |
| Jun 7, 2023 |
Jun 9, 2023 |
Henderson Jeffrey William
|
Director |
Sell |
87.5
|
+1,289
|
3.84%
|
✓
|
$122.2K |
| Jun 7, 2023 |
Jun 9, 2023 |
Schoeneck James A
|
Director |
Sell |
82.5
|
+1,189
|
1.17%
|
✓
|
$128K |
| Jun 7, 2023 |
Jun 9, 2023 |
Wettig Thane
|
Chief Commercial Officer |
Sell |
26.3
|
-1,758
|
-1.55%
|
✗
|
$30K |
| Jun 7, 2023 |
Jun 9, 2023 |
Graham Juan
|
CFO |
Sell |
26.3
|
-1,785
|
-2.45%
|
✗
|
$30.3K |
| Jun 7, 2023 |
Jun 9, 2023 |
Chung Christine
|
SVP, China Operations |
Sell |
22.5
|
-3,633
|
-1.44%
|
✗
|
$61.9K |
| Jun 7, 2023 |
Jun 9, 2023 |
Eisner Mark
|
EVP, Chief Medical Officer |
Sell |
26.3
|
-2,042
|
-1.24%
|
✗
|
$34.8K |
| Jun 7, 2023 |
Jun 9, 2023 |
Conterno Enrique A
|
CEO |
Sell |
22.5
|
-8,897
|
-2.15%
|
✗
|
$151.6K |
| Jun 2, 2023 |
Jun 5, 2023 |
Eisner Mark
|
EVP, Chief Medical Officer |
Sell |
36.3
|
-1,090
|
-0.66%
|
✗
|
$20.5K |
| Apr 10, 2023 |
Apr 11, 2023 |
Conterno Enrique A
|
CEO |
Sell |
43.8
|
-1,869
|
-0.45%
|
✗
|
$36.5K |
| Apr 4, 2023 |
Apr 6, 2023 |
Eisner Mark
|
Chief Medical Officer |
Sell |
22.5
|
-9,182
|
-5.24%
|
✗
|
$172.5K |
| Apr 4, 2023 |
Apr 6, 2023 |
Chung Christine
|
SVP, China Operations |
Sell |
22.5
|
-6,590
|
-2.54%
|
✗
|
$123.8K |
| Mar 20, 2023 |
Mar 29, 2023 |
Wettig Thane
|
Chief Commercial Officer |
Neutral |
27.5
|
-1,343
|
-1.21%
|
✗
|
- |
| Mar 23, 2023 |
Mar 24, 2023 |
Wettig Thane
|
Chief Commercial Officer |
Sell |
36.3
|
-905
|
-0.81%
|
✗
|
$16.9K |
| Mar 10, 2023 |
Mar 23, 2023 |
Conterno Enrique A
|
CEO |
Sell |
20.0
|
-19,489
|
-4.82%
|
✗
|
$393.6K |
| Mar 8, 2023 |
Mar 10, 2023 |
Chung Christine
|
SVP, China Operations |
Sell |
37.5
|
-823
|
-0.32%
|
✗
|
$330.4K |
| Mar 8, 2023 |
Mar 10, 2023 |
Conterno Enrique A
|
CEO |
Sell |
70.0
|
+4,088
|
0.21%
|
✗
|
$1.2M |
| Mar 8, 2023 |
Mar 10, 2023 |
Eisner Mark
|
Chief Medical Officer |
Sell |
85.0
|
+2,680
|
1.55%
|
✗
|
$360.6K |
| Mar 8, 2023 |
Mar 10, 2023 |
Graham Juan
|
CFO |
Sell |
47.5
|
-94
|
-0.13%
|
✗
|
$157.4K |
| Mar 8, 2023 |
Mar 10, 2023 |
Wettig Thane
|
Chief Commercial Officer |
Sell |
67.5
|
+1,203
|
0.21%
|
✗
|
$287.4K |
| Mar 2, 2023 |
Mar 6, 2023 |
Eisner Mark
|
Chief Medical Officer |
Sell |
36.3
|
-1,187
|
-0.68%
|
✗
|
$26K |
| Feb 21, 2023 |
Feb 23, 2023 |
Wettig Thane
|
Chief Commercial Officer |
Neutral |
90.0
|
+25,000
|
29.29%
|
✗
|
- |